Today, The Bowser Report issued a daily mover alert on Repro
Med Systems (REPR), which fell more than 25 percent for the day.
REPR announced that it received a warning letter from the
FDA at the end of February. The letter, according to REPR, alerted the company
to a few concerns that the FDA had after conducting an audit in June 2015.
The news, although no safety concerns were brought up,
caused investors to sell off shares midday. The selling slowed and the price
recovered a bit from its daily low of $0.28.
Currently, REPR still remains a 10, as the FDA audit hasn’t
affected the company’s fundamentals (yet, if at all). With this news, treat
REPR with a bit more speculation, but don’t write it off entirely if you don’t
have a position.
For those who enter a position or currently have a position,
follow the Game Plan. Interesting note: we originally wrote REPR up on page 8
of the July 2010 newsletter (it wasn’t a true Company of the Month). The price
at the time was $0.14 per share.
To learn more about The Bowser Report, visit
https://thebowserreport.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment